Skip to main content
. Author manuscript; available in PMC: 2013 Sep 13.
Published in final edited form as: Curr Med Res Opin. 2011 Oct 27;27(12):2309–2320. doi: 10.1185/03007995.2011.628648

Figure 2.

Figure 2

Changes in AISRS vs. changes in OCDS total scores from baseline to double-blind endpoint (or LOCF) among 61 study participants randomized to atomoxetine, and 64 randomized to placebo, who had nonmissing AISRS and OCDS data. Error bars represent 95% confidence intervals for the Pearson r correlation values. AISRS – Adult ADHD Investigator Symptom Rating Scale; ATX – atomoxetine; LOCF – last observation carried forward; OCDS – Obsessive Compulsive Drinking Scale; PLA – placebo.